|
What
is Dutasteride
The
Latest News
Dutasteride
Studies
Dutasteride
Safety Profile
FDA
Approval Documents
Dutasteride
Results
|
  |
| |
 |
| |
| Publication: |
J Am Soc Mass Spectrom 2001 Apr;12(4):385-98 |
| Authors: |
Burinsky DJ, Williams JD, Thornquest AD Jr, Sides SL. |
| Institution: |
Pharmaceutical Development Division, GlaxoSmithKline, Research Triangle Park, North Carolina 27709-3398, USA. |
| |
| Mass
spectral fragmentation reactions of a therapeutic
4-azasteroid and related compounds. |
| |
|
Mass
spectra were acquired for a therapeutic 4-azasteroid
(dutasteride), and some related compounds, using
various ionization conditions (EI, CI, APCI and
ESI) in both positive and negative ion modes. The
ionization and fragmentation behavior of the compound
dutasteride, its precursors and several analogs
is reported. Positive atmospheric pressure chemical
ionization (APCI+) and positive electrospray ionization
(ESI+) produced distinctive collision-induced dissociation
(CID) spectra for the respective [MH]+ ions of dutasteride.
The spectral differences are attributed to ion populations
having either different structures or different
internal energy distributions (as a consequence
of the method of ionization).
Irrespective of their origin, the protonated molecules
undergo interesting fragmentation reactions when
collisionally activated. The identity of the major
fragmentation products was confirmed by accurate
mass measurement. The negative APCI mass spectrum
of dutasteride displays extensive dehydrohalogenation,
apparently due to the thermal component of the APCI
process. Some of the resulting radical anions display
remarkable stability toward collisional decomposition.
Details of the fragmentation behavior for the negative
ion species and their relationship to the positive
ion results are discussed.
|
|
|
|
|